These complications are life-threatening if left untreated
Evidence involving the extract should not be attributed automatically to the synthetic tetrapeptide
In patients with MASH and F1-F3 stage fibrosis treated with survodutide for 48 weeks across doses ranging from 2.4 to 6.0 mg, regression of MASH without fibrosis progression did not show a dose-dependent trend, with the best response observed at 4.8 mg (62% vs
Proven CV safety (SELECT, 20% MACE reduction)
In einer klinischen Doppelblind-Studie, welche mit Frauen durchgefhrt wurde, die an PCOS* leiden, zeigte sich, dass die Gruppe, die L-Carnitin einnahm, im Vergleich zur Placebo-Gruppe eine regelmigere Menstruation hatte
Early expectations: First 1-2 weeks unlikely showing dramatic improvements